| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |